SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019225
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:49
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 992801
2 ex31-1.htm EX-31.1 18695
3 ex31-2.htm EX-31.2 18089
4 ex32-1.htm EX-32.1 7884
5 form10-q_001.jpg GRAPHIC 23182
  Complete submission text file 0001493152-24-019225.txt   4830631

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE fblg-20240331.xsd EX-101.SCH 34706
7 XBRL CALCULATION FILE fblg-20240331_cal.xml EX-101.CAL 48158
8 XBRL DEFINITION FILE fblg-20240331_def.xml EX-101.DEF 170246
9 XBRL LABEL FILE fblg-20240331_lab.xml EX-101.LAB 299647
10 XBRL PRESENTATION FILE fblg-20240331_pre.xml EX-101.PRE 253229
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 602087
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 24944237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)